Accepted Manuscript Treatment: Special Conditions - Metabolic Syndrome: Obesity and the Hypertension Connection Efrain Reisin, MD, FACP, FASN, FASH, Jonathan Owen, MD PII:
S1933-1711(14)00913-9
DOI:
10.1016/j.jash.2014.12.015
Reference:
JASH 620
To appear in:
Journal of the American Society of Hypertension
Please cite this article as: Reisin E, Owen J, Treatment: Special Conditions - Metabolic Syndrome: Obesity and the Hypertension Connection, Journal of the American Society of Hypertension (2015), doi: 10.1016/j.jash.2014.12.015. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT
V.
Treatment: Special Conditions E. Metabolic Syndrome: Obesity and the Hypertension Connection
TE D
M AN U
SC
RI PT
Efrain Reisin, MD, FACP, FASN, FASH Jonathan Owen, MD
Efrain Reisin, M.D.
Victor Chaltiel Professor of Medicine
EP
Chief, Section of Nephrology and Hypertension Louisiana State University Health Sciences Center
AC C
1542 Tulane Avenue
New Orleans, LA 70112 Phone: (504) 568-8655 Fax: (504) 568-2127
E-mail: [email protected]
1
ACCEPTED MANUSCRIPT
Individuals with a body mass index (BMI, Kg/square of height, m2) of 25-29.9 Kg/m2 are diagnosed as overweight and those with BMI >30 Kg/m2 as obese. Though slightly different diagnostic criteria exist, it is generally agreed that the metabolic syndrome (MS) is defined by
RI PT
the presence of three or more of the following: 1) increased waist circumference, (>40 inches for men and >35 inches for women), 2) increased triglycerides (> 150 mg/dl), 3) elevated blood pressure (>130/85 mmHg), 4) increased fasting glucose (>100 mg/dl), and 5) decreased highdensity lipoprotein cholesterol (
S1933-1711(14)00913-9
DOI:
10.1016/j.jash.2014.12.015
Reference:
JASH 620
To appear in:
Journal of the American Society of Hypertension
Please cite this article as: Reisin E, Owen J, Treatment: Special Conditions - Metabolic Syndrome: Obesity and the Hypertension Connection, Journal of the American Society of Hypertension (2015), doi: 10.1016/j.jash.2014.12.015. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT
V.
Treatment: Special Conditions E. Metabolic Syndrome: Obesity and the Hypertension Connection
TE D
M AN U
SC
RI PT
Efrain Reisin, MD, FACP, FASN, FASH Jonathan Owen, MD
Efrain Reisin, M.D.
Victor Chaltiel Professor of Medicine
EP
Chief, Section of Nephrology and Hypertension Louisiana State University Health Sciences Center
AC C
1542 Tulane Avenue
New Orleans, LA 70112 Phone: (504) 568-8655 Fax: (504) 568-2127
E-mail: [email protected]
1
ACCEPTED MANUSCRIPT
Individuals with a body mass index (BMI, Kg/square of height, m2) of 25-29.9 Kg/m2 are diagnosed as overweight and those with BMI >30 Kg/m2 as obese. Though slightly different diagnostic criteria exist, it is generally agreed that the metabolic syndrome (MS) is defined by
RI PT
the presence of three or more of the following: 1) increased waist circumference, (>40 inches for men and >35 inches for women), 2) increased triglycerides (> 150 mg/dl), 3) elevated blood pressure (>130/85 mmHg), 4) increased fasting glucose (>100 mg/dl), and 5) decreased highdensity lipoprotein cholesterol (
